Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Removal of the race coefficient and adjustment to individual BSA provide the most accurate estimation for GFR in Black adolescents

D Bielopolski, O Bentur, N Singh, R Vaughan, DM Charytan, RG Kost, JN Tobin
doi: https://doi.org/10.1101/2021.07.30.21261371
D Bielopolski
1The Rockefeller University Center for Clinical and Translational Science, New York NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: dbielopols@rockefeller.edu
O Bentur
1The Rockefeller University Center for Clinical and Translational Science, New York NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
N Singh
1The Rockefeller University Center for Clinical and Translational Science, New York NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R Vaughan
1The Rockefeller University Center for Clinical and Translational Science, New York NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DM Charytan
3Nephrology Division, New York University Langone Medical Center and Grossman School of Medicine, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RG Kost
1The Rockefeller University Center for Clinical and Translational Science, New York NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JN Tobin
1The Rockefeller University Center for Clinical and Translational Science, New York NY
2Clinical Directors Network (CDN), New York NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Introduction Obesity is more prevalent among minorities, increasing the risk for cardio-renal morbidity. We explored interactions between race, body mass index (BMI), and the risk of hyperfiltration associated with Obesity Related Glomerulopathy (ORG).

Methods We created a cohort of women and girls ages 12-21 from the New York Metropolitan area using electronic health records. Glomerular filtration rate (GFR) was estimated in three ways: I) using the standard age recommended formulae, II) eGFRr – without a race-specific coefficient, and III) Absolute eGFRr – combing removal of the race coefficient and adjusting to individual body surface area. Multivariate logistic regression was used to analyze the relative contribution of risk factors for ORG associated hyperfiltration, defined by a threshold of ≥135ml/min/1.73m2. Bland Altman analysis and Pearson’s coefficient assessed the correlation of each formula with creatinine clearance (CrCl).

Results 7315 Black and 15,102 non-Black women and girls had simultaneous evaluation of kidney function and body measures. CrCl was available in 207 non-Black and 107 Black individuals as an internal validation. Simultaneous removal of the race coefficient and adjustment to individual BSA estimated GFR most accurately compared to CrCl, across BMI groups and between races. Hyperfiltration was more frequent in obese Black compared to non-Black individuals when using standard eGFR (20% vs. 6.5% respectively) but had a lower frequency after eliminating the race-specific coefficient (4.5% vs. 6.5%). Black race was independently associated with a higher risk of hyperfiltration with standard eGFR calculations (OR=3.43, 95% CI 2.95-3.99) and with lower risk when estimated by eGFRr (OR=0.56, 95% CI 0.45-0.70). Simultaneous removal of the race coefficient from GFR calculation and adjustment to individual BSA attenuated the difference in risk between races (OR=0.8, 95% CI 0.68-0.94). The combined correction agreed well with creatinine clearance (Pearson’s correlation coefficient r=0.64, 0.52 and 0.52 for absolute eGFRr, eGFR and eGFRr respectively.

Conclusions Removal of the race coefficient from GFR estimating equations obscures obesity associated hyperfiltration among Black adolescents. This correction should be accompanied by adjustment to individual BSA to improve estimation of GFR to avoid misclassification of obesity related hyperfiltration.

Introduction

Black individuals are at higher risk of kidney diseases(1,2) accounting for one third of all kidney failures in the United Sates despite accounting for only 14% of the population(1). Decline in GFR among Black individuals occurs at an earlier age and at a faster annualized rate when compared with White Individuals, even by cystatin C–based GFR assessment(3).

This may partly relate to the disproportionately high rates of obesity in ethnic minority, low-income, and other socially marginalized US population groups. The prevalence of obesity is significantly higher in non-Hispanic Black (55%) and Hispanic (51%) than non-Hispanic White women (38%)(4), and obesity is associated with increased glomerular filtration rate (GFR), also known as hyperfiltration(5), and glomerular structural changes, such as mesangial matrix expansion, and abnormal renal hemodynamics that are reversible in early stages(6,7).

Thus, hyperfiltration in obese patients might be viewed as an early marker of kidney dysfunction, similar to glomerular hyperfiltration in patients with diabetes or hypertension that precedes the development of microalbuminuria(8,9) eventually leading to irreversible focal glomerulosclerosis(10) and the need for renal replacement therapy(11).

Estimation of eGFR is required to identify hyperfiltration as well as the presence of CKD in clinical practice, but typically relies on serum-creatinine based equations incorporating use of a race coefficient to separately estimate eGFR in Black and non-Black individuals.(12). Use of the race coefficient has been questioned by members of the nephrology community, since it has been shown to postpone timely patient referral to specialist evaluation, dialysis and transplantation (13–16). Yet, eliminating the coefficient could lead to unintended consequences such as overdiagnosis of CKD, inadequate use or dosing of drugs excreted by glomerular filtration (including metformin), and limited access to tests (including imaging procedures) and treatments that require a higher level of GFR(13). To the best of our knowledge, however, the impact of race-specific eGFR coefficient on identification of hyperfiltration, the earliest manifestation of obesity-related glomerulopathy (ORG) has not been evaluated.

Following the initiative to replace race-based equations by a substitute that is accurate, representative, and unbiased(17), we sought to analyze whether elimination of race-based equations could affect identification of ORG among minorities and to determine if race modifies the association of BMI with the risk of hyperfiltration.

Methods

Cohort construction

De-identified electronic health record data were extracted for female adolescents aged 12-21 years who received health care services from 1/1/2011 to 12/31/2015 in New York City (NYC) in 12 academic health centers and federally qualified health centers(FQHCs) that are part of the Patient Centered Outcomes Research (PCOR)-funded NYC Clinical Data Research Network (NYC-CDRN, now INSIGHT)(18).

Data-Cleaning steps for biologically plausible limits

The first encounter for each individual in which height, weight, blood pressure and serum creatinine were available was included. Extreme outlier values that might indicate data entry errors rather than true outliers were excluded by setting physiological limits for systolic blood pressure (60-220 mmHg), diastolic blood pressure (30-150 mmHg), BMI (12-80 kg/m2), height (127-200cm), weight (24-240 kg) and serum creatinine (0.3-3 mg/dL).

BMI was calculated by dividing weight in kilograms by the square of height in meters. BMI values were classified according to the Centers for Disease Control and Prevention (19) data for BMI-for-age z-score into the following categories: Underweight: BMI ≤5th percentile, Overweight: 95th≥BMI≥85th percentile, Obese: BMI ≥95th percentile, all for children and teens of the same age and sex.(19) BSA was calculated using the metric system according to the Du-Bois formula (BSA = 0.007184 * Height0.725 * Weight0.425)(20).

The cohort included adolescents from multiple races, for whom renal function were documented. Since the race coefficient relates to Black individuals in comparison to non-Black individuals(12) we divided the cohort accordingly. As part of the efforts to ascertain best clinical practice, all patients were asked to self-define their race and ethnicity.

eGFR calculation

We calculated eGFR using 3 different formulae: 1) KDIGO recommended for age formulae(21), using CKD-EPI for 18≤21 year old, and Schwartz formulae for 12-18 year old, 2) eGFRr was calculated without a race specific coefficient which applied only for Blacks 18–21 years old, as the Schwartz formula does not contain a race coefficient. 3) Absolute eGFRr - calculated without a race specific coefficient and adjusted to individual BSA.Hyperfiltration was defined according to published criteria as BSA-standardized eGFR >135 mL/min/1.73 m2 (22).

Statistical Analysis

Statistical analyses were performed using SAS (r 9.4). Nominal variables were expressed as numbers (%). Comparison of proportions between groups was performed using the chi-squared test. Continuous variables were expressed as mean ± SD and were compared using ANOVA including Dunnett’s approach for multiple comparisons, where a p<0.05 (two-tailed) was considered statistically significant.

Regression model - Univariable analyses were used to describe associations between the different variables and hyperfiltration. Multivariate logistic regression models for hyperfiltration used the predictor variables as fixed effects. These included: age, BMI, systolic and diastolic blood pressure, glycosylated Hemoglobin (HbA1c), and race. All effect estimates are presented as odds ratio (OR), along with the corresponding 95% confidence intervals (CI).

Bland Altman analysis - Bland-Altman’s analysis was used to assess the relative agreement between creatinine clearance, eGFR and absolute eGFRr. Pearson’s coefficient was used to assess correlation between continuous variables.

Ethics declaration - Data extraction and transmission were reviewed and approved, and a waiver of informed consent for analyzing de-identified data was granted by the Institutional Review Boards at Clinical Directors Network (CDN), BRANY (Biomedical Research Alliance of New York), and the Rockefeller University.

Results

Cohort construction

The cohort included 22,417 unique female patients with serum creatinine values recorded, of whom 7,315 individuals (32.6%) were Black (Table 1). A higher proportion of Black subjects (26%) were obese compared to 20% of non-Black individuals (Table 1). Blood pressure increased across BMI in both Black and White individuals, as previously described(23).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 1

Demographic and vital characteristics of Black individuals vs. non-Black individuals (22,417 patients).

Validation cohort

CrCl data from 24-hour urine collections were available for 309 individuals of whom 102 (33%) were black. CrCl increased across BMI groups for both races, of Blacks and non-Black individuals, and were statistically similar for the overweight and obese (Mean CrCL for overweight Black 132ml/min vs. overweight non-Black 130ml/min, obese Black 138ml/min vs. obese non-Black 142ml/min individuals). In contrast, eGFR values were higher for Black individuals compared to non-Blacks in every BMI group, but this pattern was reversed for the overweight and obese when using eGFRr (overweight and obese Black; 111±31, 113±31, vs. overweight and obese non-Black; 126±17, 119±21 respectively).

GFR estimation was closest to creatinine clearance when using absolute eGFRr, combing both race coefficient removal and adjustment to individual BSA, for Black individuals which was consistent across all BMI groups (Table 2 and Figure 1). Comparing absolute eGFRr for Black individuals with absolute eGFR for non-Black eliminated the differences between racial groups, across all BMI subgroups (table 2).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 2 Renal characteristics of Black individuals vs. non-Black individuals in cohort of 309 individuals with available clearance data.

eGFR – calculated according to KDIGO recommended for age formulae, eGFRr – eGFR after removal of race correction factor, applicable only for the black patients ages 18-21. For non-Black individuals values represent estimation without manipulation of race coefficient i.e instead of eGFRr>eGFR, Absolute eGFRr>Absolute eGFR. P-values for creatinine clearance subgroups represent comparison across races for these subgroups.

Figure 1
  • Download figure
  • Open in new tab
Figure 1 Measured vs. estimated GFR according to race in 309 individuals with available creatinine clearance data.

Panel A shows measured creatinine clearance according to race and BMI groups. Panel B shows measure GFR vs. different estimation formulae in Black individuals.

Renal characteristics for the full cohort

Using the standard calculation of eGFR, mean eGFR values were significantly higher across all BMI groups for Black individuals compared to non-Black individuals (Table 3). However, after eliminating the race-specific coefficient, eGFRr values were significantly lower between groups for the obese patients (119±21 ml/min/1.73m2 for obese non-Black individuals vs. 113±31 ml/min/1.73m2 for obese black individuals), although the difference was marginal. Estimated GFR remained higher in Black participants in the normal and underweight subgroups (Table 2) after elimination of the race-specific coefficient.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 3 Estimated GFR for 22,417 individuals according to the different formulae.

Numbers in brackets are number of individuals with available data. eGFR – recommended formulae for age. eGFRr – recommended formulae after removal of the race coefficient. Applied only for Black individuals ages 18-21. Absolute eGFRr – recommended formulae after removal of the race coefficient and adjusted to individual BSA. For non-Black individuals values represent estimation without manipulation of race coefficient i.e instead of eGFRr>eGFR, Absolute eGFRr>Absolute eGFR

Adjustment to individual BSA – Absolute eGFR for the non-Black individuals was similar to absolute eGFRr for Black individuals across all BMI groups, reflecting the trend observed in the validation cohort (102±26 vs. 103±25 in the overweight, 116±31 vs. 115±29 in the obese, non-Black and Black respectively, Table 3).

The prevalence of hyperfiltration was higher among Black patients compared to non-Black patients across all BMI groups with the standard estimates of eGFR (Figure 2). However, when estimated with eGFRr, hyperfiltration was less frequent amongst Black compared with non-Black participants who were overweight or obese, while remaining more frequent for the underweight group. Combining both corrections, race coefficient removal and adjustment for individual BSA, for Black individuals, compared to individual BSA adjustment for non-Blacks, created similar hyperfiltration rates across BMI groups and between racial groups (figure 2 panel C).

Figure 2
  • Download figure
  • Open in new tab
Figure 2 Hyperfiltration rates according to race and the different formulae in Black individuals vs. non-Black individuals in cohort of 22,417.

Panel A – hyperfiltration calculated by eGFR according to BMI groups in Black and non-Black individuls. Panel B - hyperfiltration rates according to eGFRr in blacks and non-Black individuals. Panel C - hyperfiltration rates in Blacks after removal of the race coefficient and adjusting for individual BSA, and in non-Black after adjustent for individual BSA.

Regression model

In both crude and adjusted models (Table 4), hyperfiltration according to all three formulae was significantly associated with age, and glycated hemoglobin (HbA1c). Associations of all three formulae with blood pressure parameters (either systolic or diastolic) were marginal for the crude and adjusted models.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 4 Regression model for hyperfiltration of Black individuals vs. non-Black individuals.

Numbers are presented as odds ratio and 95% CI. eGFR – recommended formulae for age.eGFRr - eGFR after removal of the race coefficient. Absolute eGFRr - recommended formulae after removal of the race coefficient and adjusted to individual BSA.

Race was significantly associated with hyperfiltration only for eGFR and eGFRr, but the association was borderline for the crude regression of absolute eGFRr (OR=1.11, 95% CI 1.01-1.21). According to standard eGFR, the risk of hyperfiltration was increased for Black participants (adjusted OR=3.43, 95% CI 2.95-3.99). However, when eGFR was calculated without the race-specific coefficient the risk of hyperfiltration was lower for Black compared to non-Black individuals in both crude and adjusted models: OR=0.74 (95% CI 0.66-0.83) and OR=0.56 (95% CI 0.45-0.70).

With the standard equations the risk of hyperfiltration for Black individuals was higher than in non-Black subjects across all BMI groups, although the magnitude of the association decreased at higher BMI (Supplementary table 1). When eGFR was calculated without the race-specific coefficient, Black race was significantly associated with reduced risk for hyperfiltration in the overweight and obese groups, (OR=0.7 95% CI 0.54-0.89, and OR=0.47 95%CI 0.37-0.60 respectively). The risk of hyperfiltration was identical between racial groups for the normal weight and overweight according to absolute eGFRr (OR=1.25 95% CI 0.99-1.57, OR=1.03, 95% CI 0.85-1.24 respectively), and the closest for the obese, when compared to the other two formulae (OR=0.8 95% CI 0.7-0.91).

Bland Altman analyses were performed to test the agreement between creatinine clearance, and each formula; eGFR, absolute eGFRr and absolute eGFRr across different BMI groups for Black individuals. There was a positive bias for all formulae across the complete cohort (supplementary figure 1).

Pearson’s coefficient was calculated to assess the correlation between each formula and creatinine clearance. Agreement between creatinine clearance and absolute eGFRr was better (r=0.64, p-value<.0001) than for clearance with either eGFR or eGFRr (r=0.52, p-value<.0001). Of note, removal of the race coefficient did not improve agreement between estimating formula and measured clearance.

Discussion

We examined the incidence of hyperfiltration according to eGFR and eGFRr in a large cohort of adolescents to understand the effect of the race coefficient on prevalence of ORG.

In the complete cohort estimation with the standard formula translated to increased risk of hyperfiltration among Black individuals. However, after Removal of the race coefficient, rates of hyperfiltration among black adolescents were lower compared to non-Black adolescents in the overweight and obese groups and in adjusted analyses Black individuals were significantly less likely to have hyperfiltration. Furthermore, in individuals with 24-hour urine collections, estimates of creatinine clearance were identical in Black and non-Black individuals for every BMI group except the underweight, suggesting that the estimates including the race-specific coefficient were likely misclassifying hyperfiltration. The closest estimation of GFR to clearance was achieved by combining removal of the race coefficient with adjustment to individual BSA.

Obesity may increase the risk of CKD by extenuating other components of the metabolic syndrome (such as hypertension and insulin resistance) or by inducing glomerular hyperfiltration. Hyperfiltration rates ranged between 9-11% in a population of 2043 Black adults, mean age 52, over a follow up of 8 years. These rates are lower than in our cohort, probably reflecting longer duration of obesity and progression of hyperfiltration to overt focal segmental glomerulosclerosis (FSGS) in adults(24). Hyperfiltration rates in an NHANES cohort were increased in white adolescents (9.8%) compared to Black adolescents (7.4%), yet the authors did not report BMI in their population, questioning the relevance of this finding to obesity(25). In another cohort of 1575 teenagers BMI was positively correlated with hyperfiltration but information on race was not available(26). To our knowledge, our study is the first to jointly evaluate the relative contribution of race, and obesity, to the risk hyperfiltration in adolescents.

Given the discrepancy with measured creatinine clearance, it appears that the standard equation over diagnoses hyperfiltration in Black individuals as the incidence of hyperfiltration was higher in every BMI category. In contrast, removing the race coefficient from the estimation of GFR in young women, reversed the inter-race differences in hyperfiltration rates for obese and overweight individuals.

Presumably, the race coefficient should be removed from equations estimating GFR for the entire Black population since there is no biological basis for the social construct of “race”(27). Different cohorts and equations have suggested different race coefficients, depending on GFR range of participants and percent of Black subjects included(28)(29–31)(32). Of note, the same race corrections stemming from American Blacks failed to estimate GFR of other Black populations around the world(33). Yet, removal of the race coefficient alone, as suggested by some authors(34–36), did not achieve resemblance of eGFR between races and may also lead to underdiagnosis of ORG (figure 2), masking subsequent renal damage while reclassifying some teenagers as CKD.

A few previous studies investigated the association between baseline hyperfiltration status, and subsequent GFR decline. In a population-based outpatient data set(38) higher estimated GFR (eGFR) was associated with increased risk for doubling in serum creatinine level during a median follow-up of 35 months. Two other studies found that higher baseline eGFRs predicted a steeper eGFR decline in large community cohorts (39,40). A 19-year follow-up study in patients with type 1 diabetes found that higher baseline measured GFR was associated with more rapid decline in GFR (41).

Our analysis reveals a major caveat of the currently recommended formulae to estimate GFR. As modern medicine aspires precision and individualized approach, GFR estimation and CKD management lags behind, remaining standardized and general. The use of a unanimous BSA for the entire population obscures individual risk factors for renal morbidity. In order to reduce the burden of CKD for the black population, we should focus on evaluating changeable cardiometabolic risk factors such as obesity.

Our analysis has important limitations. GFR was not measured directly using inulin or radioisotope methods which are considered the gold standard measures of renal function(42,43). Clearly, the use of these exogenous markers to estimate GFR is impractical in clinical practice; and clinical trials evaluating measured GFR do not focus on participants with normal range kidney function. In addition, our data came from adolescents in a single urban area, and the results should be generalized cautiously to other populations.

Our investigation has some obvious strengths. We explored the interaction between race and obesity in a relatively healthy young population free from confounding effects of other co-morbidities potentially causing hyperfiltration such as hypertension and diabetes. Moreover, although our data came from a single urban area, the population was large and diverse and came from multiple health care institutions.

The higher than expected prevalence of renal morbidity among Black individuals may be attributed to the combination of lower socioeconomic status(44,45), mistrust toward medical establishment(46) deterring timely evaluation and treatment, and a flawed method of GFR estimation among other causes. In the very diverse and heterogenous group of Black individuals more attention should be given to the individual risk profile rather than to the common characteristics, that do not influence physiology such as race. Unique effects of traditional risk factors, such as obesity, that are reversed by awareness, and life style modification could profoundly influence disease progression and end organ damage.

In conclusion, poor healthcare outcomes aggregate unequally. As long as uncertainty persists about the effect of racial differences on renal morbidity, we should favor practices that may alleviate health inequities over those that may exacerbate them(47).

Our data suggests that one size fits all approaches to eGFR estimation should be avoided and that eGFR equations should be revised to reflect differential risk and avoid over standardization that groups heterogenous populations under similar categories.

Data Availability

Data have been provided by the INSIGHT Clinical Research Network and can be made available upon request. The INSIGHT Governance Board will review each request.

Abbreviations

BSA
body surface area
ORG
Obesity Related Glomerulopathy
GFR
Glomerular filtration rate
CrCl
Creatinine clearance

Bibliography

  1. 1.↵
    Home | USRDS [Internet]. [cited 2020 Nov 12]. Available from: https://www.usrds.org/
  2. 2.↵
    Assari S, Burgard S. Black-White differences in the effect of baseline depressive symptoms on deaths due to renal diseases: 25 year follow up of a nationally representative community sample. J Renal Inj Prev. 2015 Dec 5;4(4):127–134.
    OpenUrl
  3. 3.↵
    Peralta CA, Vittinghoff E, Bansal N, Jacobs D, Muntner P, Kestenbaum B, et al. Trajectories of kidney function decline in young black and white adults with preserved GFR: results from the Coronary Artery Risk Development in Young Adults (CARDIA) study. Am J Kidney Dis. 2013 Aug;62(2):261–266.
    OpenUrlCrossRefPubMed
  4. 4.↵
    Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of Obesity Among Adults and Youth: United States, 2015-2016. NCHS Data Brief. 2017;(288):1–8.
  5. 5.↵
    Helal I, Fick-Brosnahan GM, Reed-Gitomer B, Schrier RW. Glomerular hyperfiltration: definitions, mechanisms and clinical implications. Nat Rev Nephrol. 2012 Feb 21;8(5):293–300.
    OpenUrlCrossRefPubMed
  6. 6.↵
    Chagnac A, Weinstein T, Korzets A, Ramadan E, Hirsch J, Gafter U. Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol. 2000 May;278(5):F817–22.
    OpenUrlPubMedWeb of Science
  7. 7.↵
    Anastasio P, Spitali L, Frangiosa A, Molino D, Stellato D, Cirillo E, et al. Glomerular filtration rate in severely overweight normotensive humans. Am J Kidney Dis. 2000 Jun;35(6):1144–1148.
    OpenUrlPubMedWeb of Science
  8. 8.↵
    Palatini P, Mormino P, Dorigatti F, Santonastaso M, Mos L, De Toni R, et al. Glomerular hyperfiltration predicts the development of microalbuminuria in stage 1 hypertension: the HARVEST. Kidney Int. 2006 Aug;70(3):578–584.
    OpenUrlPubMedWeb of Science
  9. 9.↵
    Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med. 1984 Jul 12;311(2):89–93.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    Gluba A, Mikhailidis DP, Lip GYH, Hannam S, Rysz J, Banach M. Metabolic syndrome and renal disease. Int J Cardiol. 2013 Apr 5;164(2):141–150.
    OpenUrlCrossRefPubMed
  11. 11.↵
    D’Agati VD, Chagnac A, de Vries APJ, Levi M, Porrini E, Herman-Edelstein M, et al. Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis. Nat Rev Nephrol. 2016 Jun 6;12(8):453–471.
    OpenUrlCrossRefPubMed
  12. 12.↵
    CKD Evaluation and Management – KDIGO [Internet]. [cited 2020 Nov 13]. Available from: https://kdigo.org/guidelines/ckd-evaluation-and-management/
  13. 13.↵
    Levey AS, Tighiouart H, Titan SM, Inker LA. Estimation of glomerular filtration rate with vs without including patient race. JAMA Intern Med. 2020 May 1;180(5):793– 795.
    OpenUrl
  14. 14.
    Levey AS, Titan SM, Powe NR, Coresh J, Inker LA. Kidney disease, race, and GFR estimation. Clin J Am Soc Nephrol. 2020 Aug 7;15(8):1203–1212.
    OpenUrlAbstract/FREE Full Text
  15. 15.
    Diao JA, Inker LA, Levey AS, Tighiouart H, Powe NR, Manrai AK. In search of a better equation — performance and equity in estimates of kidney function. N Engl J Med. 2021 Jan 6;
  16. 16.↵
    Diao JA, Wu GJ, Taylor HA, Tucker JK, Powe NR, Kohane IS, et al. Clinical implications of removing race from estimates of kidney function. JAMA. 2021 Jan 12;325(2):184–186.
    OpenUrlPubMed
  17. 17.↵
    Removing Race from Estimates of Kidney Function | National Kidney Foundation [Internet]. [cited 2021 Apr 28]. Available from: https://www.kidney.org/news/removing-race-estimates-kidney-function
  18. 18.↵
    Kaushal R, Hripcsak G, Ascheim DD, Bloom T, Campion TR, Caplan AL, et al. Changing the research landscape: the New York City Clinical Data Research Network. J Am Med Inform Assoc. 2014 Aug;21(4):587–590.
    OpenUrlCrossRefPubMed
  19. 19.↵
    Defining Childhood Obesity | Overweight & Obesity | CDC [Internet]. [cited 2020 Jul 30]. Available from: https://www.cdc.gov/obesity/childhood/defining.html
  20. 20.↵
    Shuter B, Aslani A. Body surface area: Du Bois and Du Bois revisited. Eur J Appl Physiol. 2000 Jun;82(3):250–254.
    OpenUrlCrossRefPubMed
  21. 21.↵
    Schwartz GJ, Muñoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol. 2009 Mar;20(3):629–637.
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    Cachat F, Combescure C, Cauderay M, Girardin E, Chehade H. A systematic review of glomerular hyperfiltration assessment and definition in the medical literature. Clin J Am Soc Nephrol. 2015 Mar 6;10(3):382–389.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    Skinner AC, Perrin EM, Moss LA, Skelton JA. Cardiometabolic risks and severity of obesity in children and young adults. N Engl J Med. 2015 Oct;373(14):1307– 1317.
    OpenUrlCrossRefPubMed
  24. 24.↵
    Olivo RE, Davenport CA, Diamantidis CJ, Bhavsar NA, Tyson CC, Hall R, et al. Obesity and synergistic risk factors for chronic kidney disease in African American adults: the Jackson Heart Study. Nephrol Dial Transplant. 2018 Jun 1;33(6):992– 1001.
    OpenUrlCrossRef
  25. 25.↵
    Lee AM, Charlton JR, Carmody JB, Gurka MJ, DeBoer MD. Metabolic risk factors in nondiabetic adolescents with glomerular hyperfiltration. Nephrol Dial Transplant. 2017 Sep 1;32(9):1517–1524.
    OpenUrl
  26. 26.↵
    Tomaszewski M, Charchar FJ, Maric C, McClure J, Crawford L, Grzeszczak W, et al. Glomerular hyperfiltration: a new marker of metabolic risk. Kidney Int. 2007 Apr;71(8):816–821.
    OpenUrlCrossRefPubMedWeb of Science
  27. 27.↵
    Is a Black race coefficient necessary for accurate evaluation of eGFR using creatinine? | AACC.org [Internet]. [cited 2021 Jun 10]. Available from: https://www.aacc.org/science-and-research/scientific-shorts/2021/is-a-black-race-coefficient-necessary-for-accurate-evaluation-of-egfr-using-creatinin
  28. 28.↵
    Rule AD, Torres VE, Chapman AB, Grantham JJ, Guay-Woodford LM, Bae KT, et al. Comparison of methods for determining renal function decline in early autosomal dominant polycystic kidney disease: the consortium of radiologic imaging studies of polycystic kidney disease cohort. J Am Soc Nephrol. 2006 Mar;17(3):854–862.
    OpenUrlAbstract/FREE Full Text
  29. 29.↵
    Delanaye P, Cohen EP. Formula-based estimates of the GFR: equations variable and uncertain. Nephron Clin Pract. 2008 Aug 18;110(1):c48.–53; discussion c54.
    OpenUrlCrossRefPubMedWeb of Science
  30. 30.
    Froissart M, Rossert J, Jacquot C, Paillard M, Houillier P. Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function. J Am Soc Nephrol. 2005 Mar;16(3):763–773.
    OpenUrlAbstract/FREE Full Text
  31. 31.↵
    Stevens LA, Coresh J, Feldman HI, Greene T, Lash JP, Nelson RG, et al. Evaluation of the modification of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol. 2007 Oct;18(10):2749–2757.
    OpenUrlAbstract/FREE Full Text
  32. 32.↵
    Peralta CA, Lin F, Shlipak MG, Siscovick D, Lewis C, Jacobs DR, et al. Race differences in prevalence of chronic kidney disease among young adults using creatinine-based glomerular filtration rate-estimating equations. Nephrol Dial Transplant. 2010 Dec;25(12):3934–3939.
    OpenUrlCrossRefPubMed
  33. 33.↵
    Delgado C, Baweja M, Burrows NR, Crews DC, Eneanya ND, Gadegbeku CA, et al. Reassessing the Inclusion of Race in Diagnosing Kidney Diseases: An Interim Report from the NKF-ASN Task Force. Am J Kidney Dis. 2021 Apr 8;
  34. 34.↵
    Eneanya ND, Yang W, Reese PP. Reconsidering the consequences of using race to estimate kidney function. JAMA. 2019 Jul 9;322(2):113–114.
    OpenUrlCrossRefPubMed
  35. 35.
    Bragg-Gresham J, Zhang X, Le D, Heung M, Shahinian V, Morgenstern H, et al. Prevalence of chronic kidney disease among black individuals in the US after removal of the black race coefficient from a glomerular filtration rate estimating equation. JAMA Netw Open. 2021 Jan 4;4(1):e2035636.
    OpenUrl
  36. 36.↵
    Zelnick LR, Leca N, Young B, Bansal N. Association of the estimated glomerular filtration rate with vs without a coefficient for race with time to eligibility for kidney transplant. JAMA Netw Open. 2021 Jan 4;4(1):e2034004.
    OpenUrl
  37. 37.
    Ahmed S, Nutt CT, Eneanya ND, Reese PP, Sivashanker K, Morse M, et al. Examining the Potential Impact of Race Multiplier Utilization in Estimated Glomerular Filtration Rate Calculation on African-American Care Outcomes. J Gen Intern Med. 2020 Oct 15;
  38. 38.↵
    Tonelli M, Klarenbach SW, Lloyd AM, James MT, Bello AK, Manns BJ, et al. Higher estimated glomerular filtration rates may be associated with increased risk of adverse outcomes, especially with concomitant proteinuria. Kidney Int. 2011 Dec;80(12):1306–1314.
    OpenUrlCrossRefPubMedWeb of Science
  39. 39.↵
    Turin TC, James M, Ravani P, Tonelli M, Manns BJ, Quinn R, et al. Proteinuria and rate of change in kidney function in a community-based population. J Am Soc Nephrol. 2013 Oct;24(10):1661–1667.
    OpenUrlAbstract/FREE Full Text
  40. 40.↵
    Baba M, Shimbo T, Horio M, Ando M, Yasuda Y, Komatsu Y, et al. Longitudinal study of the decline in renal function in healthy subjects. PLoS One. 2015 Jun 10;10(6):e0129036.
    OpenUrlCrossRefPubMed
  41. 41.↵
    Thomson HJ, Ekinci EI, Radcliffe NJ, Seah J, MacIsaac RJ, Jerums G, et al. Elevated baseline glomerular filtration rate (GFR) is independently associated with a more rapid decline in renal function of patients with type 1 diabetes. J Diabetes Complicat. 2016 Mar;30(2):256–261.
    OpenUrlPubMed
  42. 42.↵
    Swinkels DW, Hendriks JC, Nauta J, de Jong MC. Glomerular filtration rate by single-injection inulin clearance: definition of a workable protocol for children. Ann Clin Biochem. 2000 Jan;37 (Pt 1):60–66.
    OpenUrlCrossRefPubMed
  43. 43.↵
    Wilson DM, Bergert JH, Larson TS, Liedtke RR. GFR determined by nonradiolabeled iothalamate using capillary electrophoresis. Am J Kidney Dis. 1997 Nov;30(5):646–652.
    OpenUrlCrossRefPubMedWeb of Science
  44. 44.↵
    Wang Y, Beydoun MA. The obesity epidemic in the United States--gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev. 2007 May 17;29:6–28.
    OpenUrlCrossRefPubMedWeb of Science
  45. 45.↵
    Zhang Q, Wang Y. Socioeconomic inequality of obesity in the United States: do gender, age, and ethnicity matter? Soc Sci Med. 2004 Mar;58(6):1171–1180.
    OpenUrlCrossRefPubMedWeb of Science
  46. 46.↵
    Kennedy BR, Mathis CC, Woods AK. African Americans and their distrust of the health care system: healthcare for diverse populations. J Cult Divers. 2007;14(2):56–60.
    OpenUrlPubMed
  47. 47.↵
    Vyas DA, Eisenstein LG, Jones DS. Hidden in Plain Sight - Reconsidering the Use of Race Correction in Clinical Algorithms. N Engl J Med. 2020 Aug 27;383(9):874– 882.
    OpenUrlCrossRefPubMed
Back to top
PreviousNext
Posted August 05, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Removal of the race coefficient and adjustment to individual BSA provide the most accurate estimation for GFR in Black adolescents
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Removal of the race coefficient and adjustment to individual BSA provide the most accurate estimation for GFR in Black adolescents
D Bielopolski, O Bentur, N Singh, R Vaughan, DM Charytan, RG Kost, JN Tobin
medRxiv 2021.07.30.21261371; doi: https://doi.org/10.1101/2021.07.30.21261371
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Removal of the race coefficient and adjustment to individual BSA provide the most accurate estimation for GFR in Black adolescents
D Bielopolski, O Bentur, N Singh, R Vaughan, DM Charytan, RG Kost, JN Tobin
medRxiv 2021.07.30.21261371; doi: https://doi.org/10.1101/2021.07.30.21261371

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Nephrology
Subject Areas
All Articles
  • Addiction Medicine (180)
  • Allergy and Immunology (435)
  • Anesthesia (99)
  • Cardiovascular Medicine (949)
  • Dentistry and Oral Medicine (178)
  • Dermatology (111)
  • Emergency Medicine (260)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (423)
  • Epidemiology (9017)
  • Forensic Medicine (4)
  • Gastroenterology (422)
  • Genetic and Genomic Medicine (1963)
  • Geriatric Medicine (191)
  • Health Economics (405)
  • Health Informatics (1332)
  • Health Policy (662)
  • Health Systems and Quality Improvement (522)
  • Hematology (212)
  • HIV/AIDS (420)
  • Infectious Diseases (except HIV/AIDS) (10831)
  • Intensive Care and Critical Care Medicine (576)
  • Medical Education (200)
  • Medical Ethics (54)
  • Nephrology (223)
  • Neurology (1842)
  • Nursing (110)
  • Nutrition (274)
  • Obstetrics and Gynecology (357)
  • Occupational and Environmental Health (470)
  • Oncology (1006)
  • Ophthalmology (299)
  • Orthopedics (111)
  • Otolaryngology (184)
  • Pain Medicine (126)
  • Palliative Medicine (45)
  • Pathology (267)
  • Pediatrics (583)
  • Pharmacology and Therapeutics (276)
  • Primary Care Research (234)
  • Psychiatry and Clinical Psychology (1910)
  • Public and Global Health (4137)
  • Radiology and Imaging (678)
  • Rehabilitation Medicine and Physical Therapy (370)
  • Respiratory Medicine (551)
  • Rheumatology (226)
  • Sexual and Reproductive Health (191)
  • Sports Medicine (178)
  • Surgery (207)
  • Toxicology (39)
  • Transplantation (110)
  • Urology (82)